G. Losonczy (Budapest, Hungary), K. Kostikas (Karditsa, Greece)
Evaluation of the efficacy and safety of two formulations of Ipratropium bromide HFA pMDI in patients with mild to moderate chronic obstructive pulmonary disease (COPD)
S. Naik, J. Rebello, N. Morde, R. Mehta, S. Bhargava, S. Balamurugan, G. Malhotra, S. Chachad, A. Lulla, S. Purandare (Mumbai, Indore, Chennai, India)
|  |
Clinical efficacy of nebulised budesonide in acute exacerbation of COPD
G. Gaude, S. Nemagouda (Belgaum, India)
| |
Use of telehealth in the management of patients with chronic obstructive pulmonary disease (COPD)
K. S. Tan, A. Mulligan, M. Carroll, K. Carson (East Kilbride, Wishaw, United Kingdom)
| |
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD
A. James, R. Boot, E. Weersink, M. Kupczyk, R. Middelveld, E. Bel, B. Dahlén, L. Johansson, J. Aerts, S. E. Dahlén (Stockholm, Sweden; Amsterdam, Netherlands)
| |
Assessment of premature death risk after recovery from COPD exacerbation
S. Skoczynski, K. Mizia-Stec, G. Brozek, E. Sozanska, M. Ograbek-Krol, M. Tazbirek, Z. Gasior, W. Pierzchala (Katowice, Poland)
|  |
Inflammation markers: Dependence from severity of AECOPD
K. Gashynova, O. Plekhanova, T. Pertseva, E. Lykholat (Dnepropetrovsk, Ukraine)
| |
Exacerbations in COPD patients – Are they related to BMI or weight loss?
I. Gonçalves, S. Xará, L. Matos, R. Lima, M. Guimarães, N. Taveira (Vila Nova de Gaia, Portugal)
| |
Correlation between the use of statins and ACE inhibitors with the length of hospitalization for COPD exacerbations
B. Jayaraman, D. Cook, L. O‘Halloran, T. Toma (London, United Kingdom)
| |
Karnofsky index as predictor of exacerbations in moderate and severe COPD patients
L. Anoro, E. Tieso, F. Campo, D. Morillo, C. Gonzalez, A. Pérez (Zaragoza, Spain)
| |
Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation
V. Nelatur, C. McCabe, R. Butt, P. Lim, L. Hart (Slough, United Kingdom)
| |
Exacerbations of chronic obstructive pulmonary disease (COPD): Correlation of hospitalization days with epidemiological and clinical parameters
S. Nikolakopoulou, G. Hillas, D. Veldekis, P. Bakakos (Athens, Greece)
| |
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
B. Antus, I. Barta, T. Kullmann, Z. Lazar, M. Valyon, I. Horvath, E. Csiszer (Budapest, Hungary)
| |
The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation
T. Anokhina, E. Anaev, A. Karyakin, V. Apyari, S. Dmitrienko, A. Chuchalin (Moscow, Russian Federation)
| |
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
S. Ampikaipakan, C. Woodward, H. Talbot, A. Wilson (Norwich, United Kingdom)
| |
Responsiveness of a 3-min shuttle walking exercise test to assess dyspnea in COPD
F. Sava, H. Perrault, C. Brouillard, L. Cicora, C. Durauay, J. Bourbeau, F. Maltais (Canada)
| |
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
O. Mansour, A. Ali, M. Abd El-Wahed, N. Azab, S. El-dahdouh (Shebin Elkom, Egypt)
| |
Blood inflammatory patterns in different respiratory phenotypes from the general population
P. Girardi, M. Ferrari, C. Bombieri, V. Locascio, M. Olivieri, L. Perbellini, M. Nicolis, S. Sembeni, G. Verlato, Z. Maria Elisabetta, R. de Marco (Verona, Italy)
| |
Heterogeneity of regional lung ventilation in COPD patients determined by electrical impedance tomography
B. Gawelczyk, S. Pulletz, H. P. Hauber, P. Zabel, N. Weiler, I. Frerichs (Kiel, Germany)
| |
Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
H. Müllerova, V. Pinto-Plata, C. Casanova, J. P. de Torres, H. Corado, N. Varo, E. Cordoba, S. Zeineldine, F. Cortopassi, B. Celli (Uxbridge, United Kingdom; Boston, United States Of America; Santa Cruz de Tenerife, Pamplona, Spain)
| |
Exhaled nitric oxide measures using multiple flows in clinically relevant subgroups of COPD
N. Bazeghi, T. Gerds, E. Budtz-Joergensen, J. Hove, J. Vestbo (Copenhagen, Denmark; , United Kingdom)
| |